VPS74 Antibody

What is VPS74 and why is it significant in Golgi membrane research?

VPS74 (Vacuolar Protein Sorting 74) is a peripheral Golgi membrane protein that associates with membranes through its PI4P-binding site and/or a conserved β hairpin. It functions primarily as a COPI-coatomer adaptor that binds to the cytoplasmically exposed N-termini of numerous Golgi-resident integral membrane proteins (referred to as "clients") . VPS74 plays a crucial role in maintaining proper Golgi structure and function by ensuring correct localization of glycosylation enzymes and other Golgi proteins. Additionally, VPS74 acts as a sensor of PtdIns4P levels on medial Golgi cisternae and directs Sac1-mediated dephosphorylation of this PtdIns4P pool, highlighting its importance in phosphoinositide signaling regulation . Understanding VPS74 provides insights into fundamental mechanisms of protein trafficking and lipid homeostasis within the Golgi apparatus.

What are the key structural domains of VPS74 that antibodies might recognize?

VPS74 contains several structurally and functionally important domains that could serve as antibody epitopes. Structural analysis has identified two evolutionarily conserved unstructured regions: Loop1 (amino acids 78-90) and Loop2 (amino acids 165-177), which are critical for client binding . Specific residues within these loops, including W88 and D90 in Loop1 and E166, W168, and Q176 in Loop2, have been identified as the most frequent contact sites between clients and VPS74 through AlphaFold2 prediction analyses . Additionally, VPS74 contains a PI4P binding site and a β hairpin that are important for membrane association. The first 59 unstructured amino acids of VPS74 do not contribute to certain protein interactions (such as with Sac1, with a measured KD value of 4.2 ± 0.7 μM for Vps74Δ59) . When selecting antibodies for specific experiments, researchers should consider which domain they need to target based on their research question.

What are the recommended positive and negative controls for VPS74 antibody experiments?

For rigorous VPS74 antibody experiments, proper controls are essential. A negative control should include samples from vps74Δ cells, which completely lack the protein, to confirm antibody specificity and establish background signal levels . Positive controls should include samples with verified VPS74 expression, such as wild-type cells under standard growth conditions. When studying VPS74 localization, researchers should include controls with and without overexpression of client proteins (such as MNN5, KRE2, and GRX7) as well as non-client proteins (such as OCH1) to distinguish specific from non-specific effects . For co-immunoprecipitation experiments, controls should include untagged versions of VPS74 and irrelevant tagged Golgi proteins (such as Sys1-HA used in published research) to confirm specificity of interactions . When examining temperature-sensitive phenotypes, parallel experiments at permissive (25°C) and restrictive (37°C) temperatures should be conducted, as demonstrated in protocols for VPS74 immunoblotting .

How does VPS74 distribute across Golgi cisternae and how can antibodies help track this localization?

VPS74 shows a non-uniform distribution across Golgi cisternae that can be quantitatively assessed using correlation analyses with markers of different Golgi compartments. Studies using GFP-tagged VPS74 and mKate-tagged Golgi markers have demonstrated that VPS74 correlates most strongly with early and medial Golgi proteins. Specifically, GFP-Vps74 shows the highest Pearson's correlation coefficients with Cop1-mKate (r = 0.64) and Aur1-mKate (r = 0.56), which are early/medial Golgi markers . The correlation with the late Golgi resident Sec7-mKate is substantially lower (r = 0.32) . These findings align with VPS74's functional role in retaining client proteins in early/medial Golgi compartments. Antibodies against VPS74 can be used in immunofluorescence microscopy to visualize this distribution in fixed cells, while correlation analyses with known Golgi markers can quantify the degree of colocalization. The localization pattern of VPS74 is functionally significant, as it corresponds to sites where VPS74 interacts with Sac1 to regulate PI4P levels .

What protocol modifications are needed for optimal VPS74 immunoblotting?

For optimal VPS74 immunoblotting, special considerations are required during sample preparation and protein extraction. Based on published protocols, whole cell extracts should be prepared by harvesting 10^7 cells at mid-log phase (OD660 ~0.5), followed by protein precipitation with 15% trichloroacetic acid (TCA) overnight at -20°C . After centrifugation, protein pellets should be washed once with cold acetone (-20°C), air-dried, and solubilized in SDS-PAGE sample buffer containing 2.5% SDS, 50 mM NaOH, and 5 mM DTT . Proteins should be denatured by heating at 95°C for 10 minutes before SDS-PAGE separation. This protocol is particularly effective for detecting VPS74 in yeast systems and has been validated for comparing VPS74 levels under different experimental conditions, such as temperature shifts from 25°C to 37°C . The inclusion of NaOH in the sample buffer is important for efficient solubilization of membrane-associated proteins like VPS74. When detecting client proteins (MNN5, KRE2, DCR2) alongside VPS74, similar extraction methods can be employed with appropriate antibodies for each target protein .

How can researchers effectively use cross-linking approaches to study VPS74 interactions?

Cross-linking approaches have proven valuable for studying transient or weak interactions involving VPS74. For co-immunoprecipitation experiments with cross-linking, cells expressing epitope-tagged proteins (such as HA-tagged Sac1 and GFP-tagged VPS74) should be treated with an appropriate cross-linker before lysis . This stabilizes protein complexes that might dissociate during extraction. The specificity of these interactions can be confirmed by including controls with untagged proteins and irrelevant tagged proteins (such as Sys1-HA) . When investigating VPS74's interactions with client proteins, similar cross-linking approaches can be applied, with immunoprecipitation using antibodies against VPS74 or its binding partners. The choice of cross-linker and cross-linking conditions may need optimization depending on the specific interaction being studied. For interactions between VPS74 and its clients, mild cross-linking conditions might be preferable to preserve the integrity of membrane structures while stabilizing protein-protein interactions. The effectiveness of cross-linking approaches has been demonstrated in studies of the VPS74-Sac1 interaction, where a small but specific amount of interaction was detected at steady state .

What considerations are important when using nanobodies against VPS74?

Nanobodies against VPS74 offer powerful tools for research but require specific considerations for effective use. The isolation of anti-VPS74 nanobodies can be achieved using synthetic yeast surface-display libraries, following a multi-step selection process with negative selection against irrelevant proteins (e.g., Twin-Strep-tagged mNeon) and positive selection with purified Twin-Strep-tagged VPS74 . When expressing nanobodies intracellularly in yeast, N-terminal ubiquitin tagging can increase expression levels, with endogenous deubiquitinases cleaving ubiquitin to preserve the N-terminal sequence of the nanobody . Notably, some nanobodies like Vps74InNb#4 can function as inhibitors by binding to evolutionarily conserved regions on VPS74, including the β hairpin and Loop1, preventing the adaptor from binding to Golgi membranes . This inhibitory property can be leveraged for functional studies, as demonstrated in experiments where Vps74InNb#4 expression reduced the steady-state levels of VPS74 client proteins (Dcr2, Mnn5, Kre2) and caused mislocalization of clients to the vacuole . Researchers should validate nanobody binding and specificity through in vitro mixing assays and confirm the interaction interface using site-directed variants .

How can researchers distinguish between PI4P-dependent and client-dependent recruitment of VPS74 to Golgi membranes?

Distinguishing between PI4P-dependent and client-dependent recruitment of VPS74 to Golgi membranes requires multiple complementary approaches. Research has demonstrated that client overexpression is sufficient to recruit VPS74 to Golgi membranes, as evidenced by the increased number of Vps74-mNeon puncta when client genes (MNN5, KRE2, GRX7) are expressed from high copy number plasmids . This recruitment is specific to VPS74 clients, as overexpression of non-client proteins (OCH1) does not increase VPS74 puncta . To differentiate PI4P-dependent recruitment, researchers can manipulate PI4P levels through genetic approaches (e.g., manipulating PI4-kinases or phosphatases) or pharmacological inhibitors, then assess VPS74 localization. Mutations in VPS74's PI4P binding site versus mutations in client-binding regions (Loop1 and Loop2) can further help distinguish these mechanisms . The creation of chimeric proteins where only one binding capability is preserved can also provide insights. Additionally, in vitro binding assays with purified components can directly test binding preferences and potential cooperativity between PI4P and client binding. These approaches collectively enable researchers to determine the relative contributions of PI4P and client proteins to VPS74 Golgi recruitment under different conditions.

What experimental approaches can reveal the mechanism of VPS74-Sac1 interaction and its functional significance?

Multiple experimental approaches can elucidate the VPS74-Sac1 interaction and its functional significance. Biophysical methods have determined that VPS74 binds directly to the Sac1 catalytic domain with a KD value of 3.8 ± 0.4 μM, with the first 59 unstructured amino acids of VPS74 not contributing to this interaction . Yeast two-hybrid assays have shown that recognition of Sac1 by VPS74 requires the entire intact Sac1 homology region (amino acids 1-461), as no interaction was observed with constructs expressing either of the Sac1 subdomains alone . In vivo association can be confirmed through cross-linking co-immunopurification assays using epitope-tagged proteins . For functional studies, Bimolecular Fluorescence Complementation (BiFC) approaches have been used to visualize the VPS74-Sac1 interaction in living cells, revealing that this interaction occurs predominantly in early/medial Golgi compartments . To assess the functional significance of this interaction, researchers can examine PI4P levels in cells expressing wild-type versus interaction-deficient mutants of VPS74 or Sac1. The correlation between VPS74-Sac1 interaction sites and elevated PI4P in vps74Δ cells provides evidence for VPS74's role as a sensor of PtdIns4P levels that directs Sac1-mediated dephosphorylation .

What methods can identify the specific clients of VPS74 and characterize their binding interfaces?

Identifying specific VPS74 clients and characterizing their binding interfaces requires a combination of computational, biochemical, and cellular approaches. Computational methods using AlphaFold2 have successfully predicted interactions between VPS74 and client N-termini, identifying key residues in VPS74's Loop1 (W88, D90) and Loop2 (E166, W168, Q176) that frequently contact clients . These predictions can be validated through site-directed mutagenesis followed by functional assays measuring client protein stability and localization. For example, variants in these loops have been shown to compromise VPS74 function in vivo . Biochemical approaches include in vitro mixing assays with purified components to directly test binding interactions, as demonstrated with VPS74, Mnn4, and inhibitory nanobodies . At the cellular level, co-immunoprecipitation can identify clients that physically associate with VPS74, while microscopy can assess colocalization. Client dependence on VPS74 can be functionally assessed by monitoring their steady-state levels and localization in wild-type versus vps74Δ cells or cells expressing inhibitory nanobodies like Vps74InNb#4 . This nanobody approach offers an orthogonal validation of client binding, as Vps74InNb#4 binding to VPS74 prevents client interaction, leading to reduced steady-state levels of clients (Dcr2, Mnn5, Kre2) and their mislocalization to the vacuole .

How can researchers address issues with VPS74 antibody specificity and cross-reactivity?

Addressing VPS74 antibody specificity and cross-reactivity issues requires systematic validation and optimization. Researchers should first validate antibody specificity using samples from vps74Δ cells as negative controls to identify any non-specific bands . For polyclonal antibodies that show cross-reactivity, affinity purification against recombinant VPS74 protein can improve specificity. If cross-reactivity persists, epitope mapping can identify unique regions of VPS74 for developing more specific antibodies. Western blotting conditions can be optimized by adjusting blocking reagents (BSA versus milk), detergent concentrations in wash buffers, and antibody incubation times and temperatures. For applications requiring absolute specificity, researchers can generate epitope-tagged versions of VPS74 and use well-characterized tag-specific antibodies, as demonstrated in studies using GFP-tagged VPS74 . Alternatively, nanobodies against VPS74 may offer higher specificity than conventional antibodies due to their single-domain nature and can be especially valuable for applications like super-resolution microscopy. When performing co-immunoprecipitation experiments, appropriate controls (untagged proteins, irrelevant tagged proteins) are essential to distinguish specific from non-specific interactions .

What strategies can overcome detection sensitivity limitations in VPS74 immunoblotting?

Enhancing detection sensitivity for VPS74 immunoblotting requires optimization at multiple stages of the experiment. Sample preparation is critical, with TCA precipitation followed by solubilization in buffer containing 2.5% SDS and 50 mM NaOH proving effective for VPS74 detection in yeast systems . For proteins with low abundance, increasing the cell number (e.g., harvesting more than 10^7 cells) can improve detection. Pre-enrichment strategies may also help, such as isolating Golgi-enriched membrane fractions before immunoblotting. During the transfer step, using PVDF membranes (which have higher protein binding capacity than nitrocellulose) and optimizing transfer conditions for VPS74's molecular weight can improve sensitivity. For detection, enhanced chemiluminescence (ECL) substrates with higher sensitivity or fluorescently-labeled secondary antibodies with direct scanning can improve signal detection. Signal amplification systems like tyramide signal amplification can further enhance sensitivity. If antibody affinity is limiting, longer primary antibody incubation times (overnight at 4°C) may improve signal. For quantitative analyses, loading standards with known amounts of recombinant VPS74 can help establish detection limits and ensure measurements are within the linear range of detection. When investigating VPS74 under conditions where its levels might be reduced, such as high temperature growth , these sensitivity enhancements become particularly important.

How can researchers address challenges in visualizing VPS74 in immunofluorescence microscopy?

Visualization of VPS74 by immunofluorescence microscopy presents challenges due to its dynamic Golgi localization and potentially low abundance. To overcome these challenges, researchers should optimize fixation methods, testing both paraformaldehyde (which preserves structure) and methanol (which can improve accessibility to some epitopes) to determine which better preserves VPS74 antigenicity. Antigen retrieval methods may improve antibody access to epitopes in fixed specimens. For permeabilization, titrating detergent concentration is crucial to balance membrane permeabilization with preservation of Golgi structure. Signal amplification through tyramide signal amplification or higher sensitivity detection systems can enhance visualization of low-abundance VPS74. To address the dynamic nature of VPS74 localization, researchers can use client protein overexpression to stabilize VPS74 at the Golgi, as this has been shown to increase VPS74-positive puncta approximately four-fold . Co-staining with markers of different Golgi compartments helps identify the specific cisternae where VPS74 resides . For challenging applications, using fluorescently-tagged VPS74 (such as VPS74-mNeon) provides an alternative to antibody-based detection, though care must be taken to ensure the tag doesn't interfere with function . Super-resolution microscopy techniques can provide more detailed visualization of VPS74's distribution within Golgi subcompartments.

How can researchers use nanobodies for studying VPS74 function and localization?

Nanobodies offer powerful tools for studying VPS74 function and localization with advantages over conventional antibodies. The isolation of anti-VPS74 nanobodies can be achieved using synthetic yeast surface-display libraries following a multi-step selection process that includes negative selection against irrelevant proteins and positive selection with purified VPS74 . Functionally inhibitory nanobodies like Vps74InNb#4 are particularly valuable as they can bind to critical regions of VPS74 (β hairpin and Loop1) and prevent its association with Golgi membranes and client proteins . When expressed intracellularly, these nanobodies can serve as molecular tools to acutely inhibit VPS74 function, causing effects similar to genetic deletion, such as reduced steady-state levels of client proteins and their mislocalization to the vacuole . For structural studies, nanobodies can be used as crystallization chaperones to stabilize specific conformations of VPS74, as suggested by the successful prediction of the Vps74-Vps74InNb#4 complex structure using AlphaFold3 . In imaging applications, directly labeled nanobodies can provide superior resolution in super-resolution microscopy due to their small size (~15 kDa compared to ~150 kDa for conventional antibodies). Additionally, nanobodies that recognize specific functional states of VPS74 (e.g., client-bound versus free) could enable visualization of VPS74's activity cycle in live or fixed cells.

How can CRISPR-based approaches enhance VPS74 antibody applications in research?

CRISPR-based approaches can significantly enhance VPS74 antibody applications by enabling precise genetic modifications that facilitate detection and functional analysis. Researchers can use CRISPR-Cas9 to introduce endogenous epitope tags (FLAG, HA, V5) or fluorescent protein tags at the C-terminus of VPS74, allowing detection with highly specific commercial antibodies while maintaining physiological expression levels. For structure-function studies, CRISPR can generate precise point mutations in key regions identified in structural studies, such as Loop1 (W88, D90) and Loop2 (E166, W168, Q176) , allowing researchers to test the importance of these residues for client binding using antibody-based assays. CRISPR interference (CRISPRi) or CRISPR activation (CRISPRa) systems can be used to modulate VPS74 expression levels without complete knockout, enabling dose-response studies of VPS74 function. For interaction studies, CRISPR can be used to tag both VPS74 and potential client proteins, facilitating co-immunoprecipitation or proximity ligation assays. CRISPR-based approaches also enable the generation of cell lines with humanized yeast VPS74 or complementation of human cells with yeast VPS74, facilitating cross-species studies of conserved functions. These genetic tools complement antibody-based approaches by providing precisely modified systems for studying VPS74 biology.

What are the applications of VPS74 antibodies in studying disease mechanisms related to Golgi dysfunction?

VPS74 antibodies have significant potential for investigating disease mechanisms related to Golgi dysfunction. The human homologs of VPS74, GOLPH3 and GOLPH3L, have been implicated in various diseases, including cancer, where GOLPH3 is frequently amplified. VPS74 antibodies can be used to study the conserved functions between yeast VPS74 and mammalian GOLPH3/GOLPH3L, particularly in maintaining Golgi glycosylation enzyme localization . In cancer research, antibodies against GOLPH3/GOLPH3L can assess their expression levels in patient samples and correlate with disease progression. For neurodegenerative diseases involving protein trafficking defects, VPS74/GOLPH3 antibodies can help investigate alterations in Golgi morphology and function. In glycosylation disorders, these antibodies can assess the localization and abundance of glycosylation enzymes that depend on VPS74/GOLPH3 for proper Golgi retention. The inhibitory nanobody Vps74InNb#4, which binds to evolutionarily conserved regions on VPS74 and also binds to human GOLPH3 and GOLPH3L , could serve as a tool for acute inhibition studies in disease models. Phosphorylation-specific antibodies against VPS74/GOLPH3 could help investigate regulatory mechanisms in disease states, given that phosphorylation has been implicated in GOLPH3 function in cancer. These applications highlight the translational potential of VPS74 antibody research beyond basic cell biology.

What are the best practices for quantitative analysis of VPS74 protein levels and localization?

Quantitative analysis of VPS74 protein levels and localization requires rigorous methodological approaches and appropriate controls. For protein level quantification by immunoblotting, researchers should use a standard curve with known amounts of recombinant VPS74 to ensure measurements fall within the linear range of detection. Normalization to multiple housekeeping proteins or total protein staining provides more reliable quantification than single loading controls. When comparing VPS74 levels under different conditions (e.g., 25°C versus 37°C as described in the methods ), parallel processing of samples is essential to minimize technical variation. For localization studies, quantitative image analysis should include measurement of Pearson's correlation coefficients between VPS74 and various Golgi markers to determine its distribution across Golgi cisternae . When analyzing the effect of client overexpression on VPS74 localization, counting the number of VPS74-positive puncta per cell provides a quantitative measure of recruitment . To ensure reproducibility, these analyses should include multiple biological replicates (at least three independent experiments) and technical replicates (multiple fields of view or immunoblots). Statistical analysis should use appropriate tests based on data distribution, with clear reporting of sample sizes, measures of variation, and significance thresholds. Software tools for automated image analysis can reduce bias in puncta counting and colocalization measurements when properly validated.

How should researchers interpret changes in VPS74 localization and client protein interactions?

Interpreting changes in VPS74 localization and client protein interactions requires careful consideration of multiple factors. Changes in VPS74 localization may reflect alterations in Golgi structure, PI4P distribution, or client protein availability. When analyzing such changes, researchers should distinguish between total redistribution versus partial shifts in localization by using quantitative measures like Pearson's correlation coefficients with markers of different Golgi compartments . For client protein interactions, changes might indicate alterations in binding affinity, client availability, or competition between different clients. Studies showing that client overexpression increases VPS74-positive puncta suggest that client abundance can influence VPS74 localization . When interpreting results from inhibitory approaches (e.g., expression of Vps74InNb#4), researchers should consider both direct effects on VPS74-client binding and indirect effects through altered Golgi structure or function . Changes in client protein levels may result from either altered retention in the Golgi or changes in protein synthesis/degradation, necessitating pulse-chase experiments to distinguish these possibilities. The interdependence between PI4P binding and client interactions should also be considered, as mutations affecting one function may indirectly impact the other. Finally, context matters—effects observed in yeast models may differ from those in mammalian systems due to differences in Golgi organization and the expanded GOLPH3 family in mammals.

What computational approaches can predict VPS74-client protein interactions for experimental validation?

Advanced computational approaches can predict VPS74-client protein interactions for subsequent experimental validation. AlphaFold2 multimer has been successfully used to generate structures of VPS74 individually bound to nine client N-termini, identifying key residues in VPS74's Loop1 (W88, D90) and Loop2 (E166, W168, Q176) that frequently contact clients . These predictions were analyzed using structural visualization software like ChimeraX, with intermolecular interactions determined using tools that assess contacts based on van der Waals overlap . For novel client prediction, researchers can apply machine learning algorithms trained on known VPS74 clients to identify signature sequences or structural motifs in N-terminal cytoplasmic domains of Golgi proteins. Molecular dynamics simulations can model the dynamic nature of these interactions and predict the effects of mutations or post-translational modifications. Protein-protein docking algorithms can generate potential binding modes between VPS74 and candidate clients, which can be filtered based on known structural constraints. Newer tools like AlphaFold3 have been used to predict protein-protein interactions with high accuracy, as demonstrated in the modeling of the Vps74-Vps74InNb#4 complex . These computational predictions should be validated experimentally through approaches like site-directed mutagenesis, in vitro binding assays, and cellular studies examining localization and stability of predicted clients in the presence and absence of functional VPS74.